Press Releases Fresenius SE & Co. KGaA

Equities

Market Closed - Xetra Other stock markets 11:35:21 2024-05-24 am EDT			5-day change	1st Jan Change
28.93 ^EUR	+2.01%		+3.54%	+3.06%

May. 24	FMC, Fresenius and Davita rise after Ozempic news	DP
May. 23	Ailing hospitals slow down German medical technology sector	DP

Fresenius : Resolutions of the Annual General Meeting of Fresenius SE & Co. KGaA	May. 17	PU
Fresenius : Quarterly Financial Report Q1 2024 (IFRS)	May. 08	PU
Fresenius : Conference Call Q1/2024	May. 08	PU
Fresenius : exits its Investment Company Vamed	May. 08	PU
Fresenius SE & Co. KGaA: Fresenius raises outlook for fiscal year 2024	May. 07	EQ
Fresenius : divests Vamed’s rehabilitation business	May. 02	PU
Fresenius : successfully completes divestment of hospital stake in Peru	Apr. 23	PU
Fresenius Accelerates Momentum in its (Bio)Pharma Business and Launches Tyenne, its Third Approved Biosimilar in the U.S.	Apr. 16	AQ
Fresenius : Investor Relations Company Presentation	Apr. 12	PU
Fresenius : Chairman Letter	Apr. 07	PU
Fresenius : MAbxience and Teva announce strategic global license agreement for biosimilar oncology treatment	Apr. 04	PU
Fresenius : Management Board buys own shares	Apr. 04	PU
DD: Fresenius SE & Co. KGaA: Robert Möller, buy	Apr. 04	EQ
DD: Fresenius SE & Co. KGaA: Sara Hennicken, buy	Apr. 04	EQ
DD: Fresenius SE & Co. KGaA: Pierluigi Antonelli, buy	Apr. 04	EQ
DD: Fresenius SE & Co. KGaA: Michael Sen, buy	Apr. 04	EQ
AGM: Fresenius SE & Co. KGaA: Announcement of the Convening of the General Meeting in Frankfurt am Main on 17.05.2024 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution	Apr. 02	EQ
Fresenius : Meeting Participation by individual Supervisory Board member 2023	Apr. 01	PU
Fresenius : 2023 SASB Index	Apr. 01	PU
Fresenius : 2023 TCFD Index	Apr. 01	PU

No results for this search

FRESENIUS : Preparing for a strong(er) future performance

May 10, 2024 at 03:46 am EDT